Biocorp

Biocorp: Company Financial Information
 Company name  BIOCORP Production SA    ISIN:  FR0012788065
 End of Fiscal Year:  31 December 2015    Founded Year:  2015

Biocorp

(at previous day's close)
Market Cap. 90.51 m
Shares In Issue 2.96 m
Prev. Close 30.60
PE Ratio -106.36  
Dividend Yield - %
EPS – basic -0.29 c
Dividend PS - c
Dividend Cover -
Cash Flow PS -0.93 c
Return On Equity (ROE) -22.81 %
Operating Margin - %
PEG Factor -  
EPS Growth Rate - %
Dividend PS Growth Rate - %
Net Debt -1.09 m
Gross Gearing 41.13 %
Quick Assets 6.92 m
Net Working Cap 7.96 m
Intangibles / Fixed Assets 11.19 %
Turnover PS 0.83 c
Pre-Tax Profit PS -0.00 c
Retained Profit PS - c
Cash PS 203.71 c
Net Cash PS 67.19 c
Net Tangible Asset Value PS* 9.10 c
Net Asset Value PS 405.57 c
Spread 0.30 (0.98%)
*Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Biocorp Balance Sheet (31 Dec 2015)

ALCOR:liab eqALCOR:assets

Biocorp Share Price

Sample Period † High Low
1 week 28.80 31.50
4 weeks 27.10 32.00
12 weeks 27.10 37.90
1 year 23.70 38.90

Biocorp (5 years)

Biocorp Historic Returns

Period *  Open Change % Open Avg. Avg. Daily Vol [m] Total Vol. [m] VWAP
1 week 29.40 1.20 4.08 30.16 1,469.00 30.35
4 weeks 31.70 -1.10 -3.47 29.53 1,773.00 29.35
12 weeks 37.70 -7.10 -18.83 32.23 1,712.00 33.08
26 weeks 29.70 0.90 3.03 32.04 3,334.00 32.52
1 year 28.80 1.80 6.25 29.47 3,286.00 29.81
3 years 13.30 17.30 130.08 23.65 4,103.00 23.65
5 years 10.20 20.40 200.00 18.02 3,108.00 20.84
* periods calculated are whole weeks rather than calendar months

Biocorp Key Management Ratio

Biocorp Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio -23.17  
PE Ratio -106.36  
Tobin's Q Ratio -  
Tobin's Q Ratio (excl. intangibles) -  
Dividend Yield - %
Market-to-Book Ratio 7.54  
Price-to-Pre-Tax Profit PS -858,604.43  
Price-to-Retained Profit PS -  
Price-to-Cash Flow PS -32.83  
Price-to-Sales PS 36.75  
Price-to-Net Tangible Asset Value PS 3.36  
Price-to-Cash PS 0.15  
Net Working Capital PS 2.69  
Price Pct to Working Capital PS 11.37 %
Earnings Yield - %
Average PE -  
Years in Average PE -  
PE to PE average - %

Biocorp Financial Ratios

(Leverage Ratios)
Debt Ratio -22.13 %
Debt-to-Equity Ratio -0.15  
Debt-to-Equity Ratio (excl. Intgbl) -0.27  
Debt-to-Equity Market Value -0.01  
Net Gearing -9.10 %
Net Gearing (excl. Intangibles) -12.15 %
Gross Gearing 41.13 %
Gross Gearing (excl. Intangibles) 54.91 %
Gearing Under 1 Year 33.66 %
Gearing Under 1 Year (excl. Intgbl) 44.94 %
Assets / Equity 1.70  
Cash / Equity 0.85  
(Liquidity Ratios)
Net Working Capital to Total Assets 66.34 %
Current Ratio 0.67  
Quick Ratio (Acid Test) 0.56  
Liquidity Ratio 1.49  
Cash & Equiv / Current Assets 223.91 %
(Solvency Ratios)
Enterprise Value 853.81 m
Sales -1.12  
CFO / Attributable Profit -  
CFO / Assets -0.00  
CFO / Debt -0.00  
Total Debt / Equity Market Value 0.05  
Total Debt / Sales 2.00  
Total Debt / Pre-Tax Profit -4,680,226.27  
Total Debt 4.93 m
Total Debt / Net Current Assets 0.62 %
(Dodds – Graham Ratios)
3 yr Compound Earnings Growth - %
5 yr Compound Earnings Growth - %
10 yr Compound Earnings Growth - %
Earn drops > 5% in 10yrs -  
Beta (60-Mnth) Beta (36-Mnth)
- -
Alpha (60-Mnth) Alpha (36-Mnth)
- -

Biocorp Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE) - %
Return On Assets (ROA) - %
Net Profit Margin - %
Assets Turnover -  
Return On Equity (ROE) -22.81 %
Return On Investment (ROI) - %
Dividend Payout Ratio - %
Plowback Ratio - %
Growth from Plowback Ratio - %
Net Income of Revenues - %
(Asset Utilisation Multiples)
Shareholders Equity Turnover -  
Fixed Assets Turnover -  
Current Assets Turnover -  
Net Working Capital Turnover -  
Inventory Turnover -  
(Other Operating Ratios)
Total Assets-to-Sales -  
Debtors-to-Sales - %
Debt Collection Period - Days

Biocorp Dividends

Type Curr. Dividend Amount Period Start Period End Total Dividend Amount
Final EUR - 31 Dec 2014 31 Dec 2015 -
Final EUR - 31 Dec 2013 31 Dec 2014 -

Biocorp Fundamentals
  31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
Turnover - 100.00% - 100.00% 1.65 100.00% 2.46 100.00% m
Pre Tax Profit - -% - -% -0.30 -18.18% -1.05 -42.81% m
Attributable Profit - -% - -% - -% - -% m
Retained Profit - -% - -% - -% - -% m
Eps – Basic - - 0.31 -0.29
Eps – Diluted - - 0.31 -0.29
Dividends per Share - - - -

Biocorp Balance Sheet

  31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
ALCOR:liab eqALCOR:assets ALCOR:liab eqALCOR:assets
  31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
ASSETS
fixed assets  Fixed assets - -% - -% - -% - -% m
intangibles  Intangibles - -% - -% 3.29 61.54% 3.01 25.10% m
fixed investments  Fixed Investments - -% - -% 0.04 0.78% 0.27 2.24% m
current assets - other  Current Assets – Other - -% - -% 1.04 19.36% 1.38 11.52% m
stocks  Stocks - -% - -% 0.46 8.59% 0.41 3.44% m
debtors  Debtors - -% - -% 0.45 8.50% 0.90 7.48% m
cash & securities  Cash & securities - -% - -% 0.07 1.22% 6.03 50.23% m
Other assets - -% - -% 0.00 0.03% 0.00 0.01% m
TOTAL - -% - -% 5.35 100.00% 12.00 100.00% m
LIABILITIES
creditors - short  Creditors – Short - -% - -% 3.84 958.63% 4.04 57.18% m
creditors - long  Creditors – Long - -% - -% 1.11 276.23% 0.90 12.68% m
TOTAL - -% - -% 4.95 1,234.86% 4.93 69.86% m
EQUITY
Minority Interest - -% - -% -0.40 -100.00% -7.06 -100.00% m
Capital Reserves - -% - -% 0.40 100.00% 7.06 100.00% m
TOTAL - -% - -% 0.40 100.00% 7.06 100.00% m

Biocorp Cash Flow Statement

31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
Operating CF - - -1.45 -2.76
Investing CF - - -0.60 -0.71
Financial CF - - 2.15 9.46
Net change CF - - 0.10 6.00

Biocorp Employee Data

31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
Number of employees - - 21.00 -
Sales per employee - - 0.08 - m

Data supplied by
ADVFN Advertorial
Your Recent History
EU
ALCOR
Biocorp
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220629 07:33:33